BridgeMD
Tests treatment safety and results for Suicidal Ideation and Behavior
Official title Design and Feasibility of an SMS-based Safety Planning Intervention
ClinicalTrials.gov ID: NCT07365579
What this study is testing
- What it's testing
- This study is testing whether it is feasible to run a larger randomized controlled trial and whether an automated text messaging program is acceptable to young adults who have suicidal thoughts. The program is designed to help participants create and use a safety plan, which is a personalized list of warning signs, coping strategies, supportive people, professional resources, ways to make their environment safer, and reasons for living.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 24
You may be able to join if
- Ages 18 to 24 \ The age to provide consent in Nebraska is 19. Individuals recruited from the state of Nebraska must be 19 or older.
- endorsement of past 2-week suicidal ideation
- Resident of the United States
- Owns a smartphone
You likely can't join if
- Serious mental illness for which intervention would be contraindicated (i.e., active psychosis or mania)
- Imminent suicidality (i.e., experiencing active suicidal ideation with a plan and intent to act)
- Written English language skills that are insufficient to engage in the consent, design, evaluation, or intervention procedures.
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 24 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.